Best Medical Treatment and Selective Stent-GraftRepair for Acute Type B Aortic Intramural Hematoma
Gabriele Piffaretti1, Chiara Lomazzi2, Filippo Benedetto3
1Vascular Surgery, Department of Surgery and Morphological Sciences, Circolo University Teaching Hospital, University of Insubria School of Medicine, Varese, Italy.
Insights
Stent-graft (SG) repair for acute type B aortic intramural hematoma (B-IMH) shows encouraging mid-term results. While SG repair may reduce aortic-related mortality, it can also lead to lower freedom from aortic progression.
Area of Science:
- Cardiovascular Surgery
- Vascular Surgery
- Interventional Cardiology
Background:
- Acute type B aortic intramural hematoma (B-IMH) is a variant of acute aortic dissection.
- Management strategies for B-IMH, particularly the role of stent-graft (SG) repair, require further elucidation.
- Ulcer-like projections on computed tomography angiography may predict the need for intervention in B-IMH patients.
Purpose of the Study:
- To describe the management and outcomes of stent-graft (SG) repair for acute type B aortic intramural hematoma (B-IMH).
- To evaluate early and long-term survival, aortic remodeling, freedom from aortic-related mortality (ARM), and freedom from reintervention after SG repair.
- To compare outcomes between patients treated with SG in acute versus chronic phases and assess the impact of medical management alone.
Main Methods:
- Retrospective analysis of 41 patients with B-IMH treated between January 2005 and July 2016.
- Thirty-one patients underwent SG repair, with interventions performed in acute, subacute, and chronic phases.
- Assessment of major end points including survival, aortic remodeling, ARM, and reintervention rates, with a median follow-up of 31 months.
Main Results:
- Thirty-one (76%) patients underwent SG repair, with 16 in the acute phase and 6 in the subacute phase.
- Nine (29%) patients required SG repair in the chronic phase due to aortic lesion progression despite medical management.
- At 12 months, SG repair showed a trend towards lower ARM (84% ± 10 vs. 100%; P=.075) but significantly lower freedom from aortic progression (64% ± 13 vs. 94% ± 5; P=.002).
- Freedom from ARM and reintervention was 92% ± 5 at 12 months. Aortic remodeling was observed in 84% of patients.
- Best medical treatment alone was associated with a 47% adverse aortic event rate in follow-up.
Conclusions:
- Stent-graft repair for B-IMH is associated with encouraging mid-term results, including high rates of aortic remodeling and freedom from aortic-related mortality and reintervention.
- The presence of ulcer-like projections on initial computed tomography angiography is a significant predictor for requiring SG repair.
- While SG repair may reduce ARM, it is associated with a higher rate of aortic progression compared to best medical treatment alone, highlighting the need for careful patient selection and monitoring.
Abstract:
This study aimed to describe our experience with the management and the results of stent-graft (SG) repair of acute type B aortic intramural hematoma (B-IMH). Between January 2005 and July 2016, we identified 41 B-IMHs. Major end points were early and long-term survival, aortic remodeling, freedom from aortic-related mortality (ARM), and freedom from reintervention. Thirty-one (76%) patients eventually underwent SG repair: 16 (52%) cases in the acute phase, and 6 (19%) in the subacute (14-30 days) phase. Nine (29%) patients showed aortic lesion progression in the follow-up despite best medical treatment, and required SG repair in the chronic phase. The presence of ulcer-like projections at the admission computed tomography angiography was significantly higher in patients who eventually required SG repair (5% vs 36%, odds ratio: 4.08, P = .043). At 12 months, whereas ARM showed a trend in favor of SG (84% ± 10 vs 100%; log-rank: P = .075), the freedom from aortic progression was significantly lower in the SG group (64% ± 13 vs 94% ± 5; log-rank: P = .002). Median follow-up was 31 months (range, 2-96; interquartile range, 11-62.5). Freedom from ARM and freedom from aortic reintervention was 92% ± 5 (95% confidence interval: 75-98) at 12 months. Aortic remodeling was observed in 26 (84%) patients. No differences were noted between patients treated with SG in the acute and in the chronic phase. In our experience, B-IMH was associated with 47% aortic adverse event rate in the follow-up with best medical treatment alone. At mid-term, results of SG repair are encouraging.
Related Concept Videos
Types of Selection
Aortic Regurgitation III: Medical Management
Overview of DNA Repair
Chemically...
Mismatch Repair
Nucleotide Excision Repair
Base Excision Repair
The first step of...


